CHS INC - CHSINC 7.1 PERP (CHSCN) Fundamental Analysis & Valuation
NASDAQ:CHSCN • US12542R5063
Current stock price
25.2 USD
-0.05 (-0.2%)
Last:
This CHSCN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHSCN Profitability Analysis
1.1 Basic Checks
- In the past year CHSCN had a positive cash flow from operations.
- CHSCN had positive earnings in each of the past 5 years.
- In the past 5 years CHSCN always reported a positive cash flow from operatings.
1.2 Ratios
- CHSCN has a Return On Assets (2.96%) which is in line with its industry peers.
- CHSCN has a Return On Equity (5.48%) which is in line with its industry peers.
- CHSCN has a Return On Invested Capital (0.37%) which is in line with its industry peers.
- CHSCN had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 6.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROIC | 0.37% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
- CHSCN has a Profit Margin (1.75%) which is in line with its industry peers.
- CHSCN's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 0.21%, CHSCN is in line with its industry, outperforming 41.38% of the companies in the same industry.
- In the last couple of years the Operating Margin of CHSCN has declined.
- With a Gross Margin value of 3.21%, CHSCN is not doing good in the industry: 80.46% of the companies in the same industry are doing better.
- CHSCN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. CHSCN Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHSCN is destroying value.
- Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.10 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
- CHSCN has a Altman-Z score (2.10) which is comparable to the rest of the industry.
- CHSCN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
- CHSCN has a better Debt to Equity ratio (0.32) than 64.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.1 |
ROIC/WACC0.07
WACC5.45%
2.3 Liquidity
- A Current Ratio of 1.42 indicates that CHSCN should not have too much problems paying its short term obligations.
- The Current ratio of CHSCN (1.42) is comparable to the rest of the industry.
- A Quick Ratio of 0.80 indicates that CHSCN may have some problems paying its short term obligations.
- CHSCN has a Quick ratio (0.80) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 |
3. CHSCN Growth Analysis
3.1 Past
- Looking at the last year, CHSCN shows a decrease in Revenue. The Revenue has decreased by -5.74% in the last year.
- Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CHSCN Valuation Analysis
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CHSCN is valued cheaper than 96.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.36 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CHSCN Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.26%, CHSCN is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 2.22, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 90.80% of the companies listed in the same industry.
- CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.26% |
5.2 History
- CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
- CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years11
5.3 Sustainability
- 27.52% of the earnings are spent on dividend by CHSCN. This is a low number and sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CHSCN (4/21/2026, 8:00:01 PM)
25.2
-0.05 (-0.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-15 2026-04-15
Earnings (Next)07-07 2026-07-07
Inst Owners11.07%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap309.20M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.25%
Short Ratio1.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.26% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years11
Ex-Date06-15 2026-06-15 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.52 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.36 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY191.45%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROCE | 0.54% | ||
| ROIC | 0.37% | ||
| ROICexc | 0.38% | ||
| ROICexgc | 0.38% | ||
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 96.64% | ||
| Cap/Sales | 1.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.1 |
F-Score4
WACC5.45%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 7.1 PERP / CHSCN Fundamental Analysis FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
What is the valuation status for CHSCN stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
How profitable is CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.